• 1. Naphthopyranones – isolation, bioactivity, biosynthesis and synthesis
  Christopher D. Donner Nat. Prod. Rep. 2015 32 578
• 2. Discovery of potential hypoglycemic metabolites in Cassiae Semen by coupling UHPLC-QTOF-MS/MS combined plant metabolomics and spectrum-effect relationship analyses
  Fei Yang,Yanfang Zou,Chenyue Li,Jiaxu Li,Yaping Zang,Xin Peng,Juan Wang,E-Hu Liu,Shengqiang Tong,Chu Chu Food Funct. 2022 13 10291
• 3. Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics
  Prarambh S. R. Dwivedi,Rajesh Patil,Pukar Khanal,Nilambari S. Gurav,Vaishali D. Murade,Dinesh P. Hase,Mohan G. Kalaskar,Muniappan Ayyanar,Rupesh V. Chikhale,Shailendra S. Gurav RSC Adv. 2021 11 39362
• 4. Glycosylation with glycosyl N-phenyltrifluoroacetimidates (PTFAI) and a perspective of the future development of new glycosylation methods
  Biao Yu,Jiansong Sun Chem. Commun. 2010 46 4668
• 5. Naturally occurring inhibitors against the formation of advanced glycation end-products
  Xiaofang Peng,Jinyu Ma,Feng Chen,Mingfu Wang Food Funct. 2011 2 289

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Naphthopyrans Naphthopyranone glycosides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Naphthopyrans Naphthopyranones Naphthopyranone glycosides
• Anthraquinones

Recent Advances in the Study of Cassiaside (123914-49-8): A Comprehensive Research Brief

Cassiaside (CAS: 123914-49-8) is a bioactive compound derived from the Cassia species, which has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have focused on elucidating its pharmacological properties, mechanisms of action, and potential clinical uses. This research brief aims to provide an up-to-date synthesis of the latest findings related to Cassiaside, with a particular emphasis on its chemical structure, biological activities, and emerging applications in medicine.

The chemical structure of Cassiaside (123914-49-8) features a unique glycosidic linkage, which is believed to contribute to its bioactivity. Recent structural-activity relationship (SAR) studies have highlighted the importance of this moiety in mediating interactions with biological targets, such as enzymes and receptors. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to characterize the compound and its derivatives, providing insights into its stability and reactivity under physiological conditions.

In vitro and in vivo studies have demonstrated that Cassiaside exhibits a range of pharmacological effects, including anti-inflammatory, antioxidant, and neuroprotective properties. For instance, a 2023 study published in the Journal of Natural Products revealed that Cassiaside significantly reduces oxidative stress in neuronal cells by modulating the Nrf2/ARE signaling pathway. These findings suggest its potential utility in treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.

Another area of active research is the compound's role in metabolic regulation. A recent preclinical trial reported in Biochemical Pharmacology (2024) showed that Cassiaside enhances insulin sensitivity and glucose uptake in adipocytes, indicating its promise as a therapeutic agent for type 2 diabetes. Mechanistic studies further identified AMPK activation as a key pathway through which Cassiaside exerts its metabolic effects.

Despite these promising findings, challenges remain in the development of Cassiaside-based therapies. Issues such as bioavailability, pharmacokinetics, and potential toxicity require further investigation. Recent efforts have focused on optimizing delivery systems, including nanoparticle formulations, to improve the compound's solubility and tissue targeting. A 2024 study in the International Journal of Pharmaceutics demonstrated that liposomal encapsulation of Cassiaside significantly enhances its bioavailability in animal models.

In conclusion, Cassiaside (123914-49-8) represents a promising candidate for drug development, with diverse pharmacological activities and potential applications in multiple therapeutic areas. Ongoing research is expected to further elucidate its mechanisms of action and address current limitations, paving the way for clinical translation. This brief underscores the importance of continued investment in the study of natural products like Cassiaside, which hold significant potential for addressing unmet medical needs.

• 84272-85-5(5-O-Methylvisammioside)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)